Sugentech Inc (KQ:253840) — Market Cap & Net Worth
Market Cap & Net Worth: Sugentech Inc (253840)
Sugentech Inc (KQ:253840) has a market capitalization of $39.37 Million (₩58.10 Billion) as of August 4, 2026. Listed on the KQ stock exchange, this Korea-based company holds position #22734 globally and #1444 in its home market, demonstrating a -7.09% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Sugentech Inc's stock price ₩3800.00 by its total outstanding shares 15289668 (15.29 Million). See Sugentech Inc capital reinvestment ratio to understand how much of operating cash flow is reinvested back into capital assets.
Sugentech Inc Market Cap History: 2019 to 2026
Sugentech Inc's market capitalization history from 2019 to 2026. Data shows change from $54.84 Million to $39.37 Million (-12.36% CAGR).
Index Memberships
Sugentech Inc is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
Kosdaq Composite Index
KOSDAQ
|
$202.56 Billion | 0.02% | #698 of 1384 |
|
Kosdaq Composite Index
KQ11
|
$202.56 Billion | 0.02% | #698 of 1384 |
Weight: Sugentech Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Sugentech Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Sugentech Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.01x
Sugentech Inc's market cap is 0.01 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2019 | $54.84 Million | $3.85 Billion | -$9.56 Billion | 0.01x | N/A |
| 2020 | $203.16 Million | $41.35 Billion | -$41.02 Billion | 0.00x | N/A |
| 2021 | $140.11 Million | $77.20 Billion | $36.15 Billion | 0.00x | 0.00x |
| 2022 | $103.13 Million | $101.40 Billion | $26.72 Billion | 0.00x | 0.00x |
| 2023 | $80.30 Million | $7.13 Billion | -$17.24 Billion | 0.01x | N/A |
| 2024 | $55.23 Million | $10.10 Billion | -$15.19 Billion | 0.01x | N/A |
| 2025 | $63.62 Million | $9.42 Billion | -$23.31 Billion | 0.01x | N/A |
Competitor Companies of 253840 by Market Capitalization
Companies near Sugentech Inc in the global market cap rankings as of August 4, 2026.
Key companies related to Sugentech Inc by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #114 globally with a market cap of $183.80 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #189 globally with a market cap of $124.64 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #233 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
- Medtronic PLC (NYSE:MDT): Ranked #238 globally with a market cap of $103.60 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #114 | Abbott Laboratories | NYSE:ABT | $183.80 Billion | $105.70 |
| #189 | Stryker Corporation | NYSE:SYK | $124.64 Billion | $325.70 |
| #233 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
| #238 | Medtronic PLC | NYSE:MDT | $103.60 Billion | $85.39 |
Sugentech Inc Historical Marketcap From 2019 to 2026
Between 2019 and today, Sugentech Inc's market cap moved from $54.84 Million to $ 39.37 Million, with a yearly change of -12.36%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ₩39.37 Million | -38.11% |
| 2025 | ₩63.62 Million | +15.20% |
| 2024 | ₩55.23 Million | -31.23% |
| 2023 | ₩80.30 Million | -22.13% |
| 2022 | ₩103.13 Million | -26.39% |
| 2021 | ₩140.11 Million | -31.03% |
| 2020 | ₩203.16 Million | +270.44% |
| 2019 | ₩54.84 Million | -- |
End of Day Market Cap According to Different Sources
On Aug 3rd, 2026 the market cap of Sugentech Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $39.37 Million USD |
| MoneyControl | $39.37 Million USD |
| MarketWatch | $39.37 Million USD |
| marketcap.company | $39.37 Million USD |
| Reuters | $39.37 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Sugentech Inc
Sugentech Inc. develops and sells in-vitro diagnostic systems and products based on biotechnology, information technology, and nanotechnology in South Korea and internationally. The company offers lab tests, including systems and test items; and COVID-19 tests. It also provides point of care testing analyzers and test items for testing of influenza A/B, antibody test, COVID-19 and flu, SARS-CoV-2… Read more